Update date
30 Jun 2025
Shareable Research Card
This metric view shows IMRN - Immuron Ltd liabilities history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported liabilities: A$2,060,787. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
30 Jun 2025
Page type
Metric history
Latest period
Q2 2025
SEC-backed company facts were refreshed from filings filed on 25 Sep 2025.
Benchmark Context
Immuron Ltd sits in the bottom quarter of the current liabilities sample.
Compared with
Compared with 19 companies reporting liabilities in AUD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.2x the current sample midpoint. Liabilities is down about 27% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Latest period: Q2 2025. Period end: 30 Jun 2025. Units: AUD and USD. Frequency: quarterly.
Liabilities is an SEC-reported metric from company XBRL facts.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare latest available Liabilities levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Immuron Ltd appears at rank #19 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | WESTPAC BANKING CORP (webnf) | A$1,005,492,000,000 | Instant - 30 Sep 2024 | Open WESTPAC BANKING CORP Liabilities |
| 2 | Telix Pharmaceuticals Ltd (tlx) | A$948,218,000 | Instant - 31 Dec 2024 | Open Telix Pharmaceuticals Ltd Liabilities |
| 3 | Carbon Revolution Public Ltd Co (crevf) | A$251,862,000 | Instant - 30 Jun 2024 | Open Carbon Revolution Public Ltd Co Liabilities |
| 4 | Elevra Lithium Ltd (elvr) | A$177,268,000 | Instant - 30 Jun 2025 | Open Elevra Lithium Ltd Liabilities |
| 5 | NOVONIX Ltd (nvx) | A$75,218,083 | Instant - 30 Jun 2022 | Open NOVONIX Ltd Liabilities |
| 6 | KAZIA THERAPEUTICS LTD (kzia) | A$31,602,000 | Instant - 30 Jun 2024 | Open KAZIA THERAPEUTICS LTD Liabilities |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | A$2,060,787 | -A$779,738 | -27% | 30 Jun 2025 | 20-F | 25 Sep 2025 | 2025 | FY |
| Q2 2024 | A$2,840,525 | +A$469,179 | +20% | 30 Jun 2024 | 20-F | 25 Sep 2025 | 2025 | FY |
| Q2 2023 | A$2,371,346 | +A$692,923 | +41% | 30 Jun 2023 | 20-F | 25 Sep 2025 | 2025 | FY |
| Q2 2022 | A$1,678,423 | +A$520,374 | +45% | 30 Jun 2022 | 20-F | 01 Oct 2024 | 2024 | FY |
| Q2 2021 | A$1,158,049 | +A$599,799 | +107% | 30 Jun 2021 | 20-F | 28 Sep 2023 | 2023 | FY |
| Q2 2020 | A$558,250 | -A$652,261 | -54% | 30 Jun 2020 | 20-F | 09 Sep 2022 | 2022 | FY |
| Q2 2019 | A$1,210,511 | +A$407,173 | +51% | 30 Jun 2019 | 20-F | 29 Oct 2021 | 2021 | FY |
| Q2 2018 | A$803,338 | -A$908,227 | -53% | 30 Jun 2018 | 20-F | 28 Oct 2020 | 2020 | FY |
| Q2 2017 | A$1,711,565 | -A$2,175,356 | -56% | 30 Jun 2017 | 20-F | 28 Oct 2019 | 2019 | FY |
| Q2 2016 | A$3,886,921 | 30 Jun 2016 | 20-F | 31 Oct 2018 | 2018 | FY |
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | $2,356,201 | +$519,676 | +28% | 31 Dec 2023 | 6-K/A | 28 May 2024 | 2024 | Q2 |
| Q2 2023 | $2,371,346 | 30 Jun 2023 | 6-K/A | 28 May 2024 | 2024 | Q2 | ||
| Q4 2022 | $1,836,525 | 31 Dec 2022 | 6-K/A | 28 May 2024 | 2024 | Q2 | ||
| Q4 2019 | $1,521,687 | +$1,000,453 | +192% | 31 Dec 2019 | 6-K/A | 19 Jun 2020 | 2019 | Q2 |
| Q2 2019 | $1,210,511 | 30 Jun 2019 | 6-K/A | 19 Jun 2020 | 2019 | Q2 | ||
| Q4 2018 | $521,234 | 31 Dec 2018 | 6-K/A | 19 Jun 2020 | 2019 | Q2 |